These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339 [Abstract] [Full Text] [Related]
3. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Lemesre JL, Holzmuller P, Cavaleyra M, Gonçalves RB, Hottin G, Papierok G. Vaccine; 2005 Apr 22; 23(22):2825-40. PubMed ID: 15780731 [Abstract] [Full Text] [Related]
5. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi. Vinhas V, Freire M, Bacellar O, Cunha S, Rocha H, Carvalho EM. Braz J Med Biol Res; 1994 May 22; 27(5):1199-205. PubMed ID: 8000341 [Abstract] [Full Text] [Related]
9. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis. Carrillo E, Crusat M, Nieto J, Chicharro C, Thomas Mdel C, Martínez E, Valladares B, Cañavate C, Requena JM, López MC, Alvar J, Moreno J. Vaccine; 2008 Mar 28; 26(15):1902-11. PubMed ID: 18321614 [Abstract] [Full Text] [Related]
11. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells. Carrión J, Folgueira C, Alonso C. Vaccine; 2008 May 12; 26(20):2537-44. PubMed ID: 18400342 [Abstract] [Full Text] [Related]
13. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response. Ramos I, Alonso A, Marcen JM, Peris A, Castillo JA, Colmenares M, Larraga V. Vaccine; 2008 Jan 17; 26(3):333-44. PubMed ID: 18093705 [Abstract] [Full Text] [Related]
14. Domestic swine in a visceral leishmaniasis endemic area produce antibodies against multiple Leishmania infantum antigens but apparently resist to L. infantum infection. Moraes-Silva E, Antunes FR, Rodrigues MS, da Silva Julião F, Dias-Lima AG, Lemos-de-Sousa V, de Alcantara AC, Reis EA, Nakatani M, Badaró R, Reis MG, Pontes-de-Carvalho L, Franke CR. Acta Trop; 2006 May 17; 98(2):176-82. PubMed ID: 16730628 [Abstract] [Full Text] [Related]
16. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals. Khoshgoo N, Zahedifard F, Azizi H, Taslimi Y, Alonso MJ, Rafati S. Vaccine; 2008 Oct 29; 26(46):5822-9. PubMed ID: 18804512 [Abstract] [Full Text] [Related]
18. Imprinting of BALB/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge. Ferrua B, Luci C, Le Fichoux Y, Paul A, Marty P. Vaccine; 2006 Jan 30; 24(5):589-96. PubMed ID: 16157427 [Abstract] [Full Text] [Related]